This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The award, valued at $51,581.80, is for the delivery of 300 mg/15 ml vials of the pharmaceutical product Tysabri.
The contract has a completion date of January 6, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.
Generated 3/13/25, 9:51 AM